Skip to main content

Undercover actress-playwright Rebecca Northan.

It should be no surprise that the latest play from Rebecca Northan involves a murder, because the playwright and actress has been killing it on Toronto stages for years. Undercover, the new piece co-written by the creator of the Dora Award winning Blind Date, involves an audience member who gets to go gumshoe as a rookie detective on the big case. As for Northan, she gave The Globe and Mail plenty of clues as to what she likes to investigate when she's off-duty.

What she's watching: "The Break on Netflix. It's a French murder-mystery series. I have been exclusively watching mysteries, cop dramas, British cozies, etc., for six months in preparation for my new play Undercover. I think I've watched enough to start solving cases in real life! Also, I like learning to swear like a French cop."

What she's reading: "I am loving The Hero Within: Six Archetypes We Live By, by Carol S. Pearson. I'm 100 per cent into the heroic archetypes we all live by, and because reading this book is way cheaper than going to therapy."

Story continues below advertisement

What she's looking forward to: "The Virgin Trial by Kate Hennig, at the Stratford Festival until Oct. 8. Kate is a good friend, a mentor, an inspiration and a genius. Her use of language is both brilliant and funny. She also writes some seriously kick-ass female characters. Sexual and political intrigue in the Tudor court! Who doesn't want to see that?"

Undercover runs to Oct. 29 at the Tarragon Mainspace, $29 to $60. 30 Bridgman Ave., 416-531-1827 or tarragontheatre.com

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies